HCMT
GNMK

Highland Capital Management (Texas)’s GenMark Diagnostics, Inc GNMK Stock Holding History

Highland Capital Management (Texas)’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-102,611
Closed -$1.02M – 315
2014
Q1 		$1.02M Buy
102,611
+66,042
+181% +$821K 0.04% 158
2013
Q4 		$486K Sell
36,569
-27,159
-43% -$330K 0.03% 146
2013
Q3 		$774K Buy
+63,728
New +$683K 0.05% 119

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Highland Capital Management (Texas)'s GNMK Position: Q2 2014 in Review

Highland Capital Management (Texas) sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2014, closing a stake of 102,611 shares — an estimated $1.02M sold.

Highland Capital Management (Texas) first reported a position in GNMK in Q3 2013 and held it in 3 quarters. The position peaked at $1.02M in Q1 2014. 78 funds tracked by Wall St. Rank hold GNMK as of Q2 2014.

  • Highland Capital Management (Texas) reported no remaining GenMark Diagnostics, Inc position as of Q2 2014 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 102,611 GenMark Diagnostics, Inc shares in Q2 2014, an estimated $1.02M.
  • Highland Capital Management (Texas) first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 3 quarters.
  • Highland Capital Management (Texas)'s GenMark Diagnostics, Inc position peaked at $1.02M in Q1 2014.
  • 78 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2014.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2014, filed 14 Aug 2014.